Shares of AptarGroup Inc. (NYSE:ATR) have been given an average recommendation of “Hold” by the nine research firms that are covering the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating on the company. The average 1 year target price among analysts that have covered the stock in the last year is $79.67.

Several equities research analysts have commented on the stock. Robert W. Baird raised their price target on shares of AptarGroup from $80.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday, September 9th. BMO Capital Markets restated a “hold” rating on shares of AptarGroup in a research note on Friday, September 9th. Finally, Jefferies Group assumed coverage on shares of AptarGroup in a research note on Thursday. They issued a “hold” rating and a $83.00 price target on the stock.

AptarGroup (NYSE:ATR) opened at 76.03 on Friday. The firm has a 50-day moving average price of $77.70 and a 200 day moving average price of $77.69. The firm has a market capitalization of $4.78 billion, a P/E ratio of 24.69 and a beta of 0.87. AptarGroup has a one year low of $66.33 and a one year high of $81.50.

AptarGroup (NYSE:ATR) last announced its quarterly earnings results on Thursday, July 28th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. AptarGroup had a net margin of 8.54% and a return on equity of 16.67%. The company had revenue of $620 million for the quarter, compared to analyst estimates of $621.52 million. During the same quarter last year, the business earned $0.82 earnings per share. AptarGroup’s revenue was up 4.3% compared to the same quarter last year. Equities research analysts anticipate that AptarGroup will post $3.18 earnings per share for the current year.

In related news, Director King W. Harris sold 13,100 shares of the firm’s stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $76.62, for a total transaction of $1,003,722.00. Following the completion of the sale, the director now directly owns 195,509 shares in the company, valued at $14,979,899.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Salim Haffar sold 50,333 shares of the firm’s stock in a transaction that occurred on Friday, September 2nd. The stock was sold at an average price of $78.74, for a total transaction of $3,963,220.42. Following the sale, the insider now owns 23,149 shares of the company’s stock, valued at $1,822,752.26. The disclosure for this sale can be found here. Corporate insiders own 5.50% of the company’s stock.

A number of hedge funds have recently modified their holdings of ATR. C M Bidwell & Associates Ltd. boosted its stake in shares of AptarGroup by 16.9% in the first quarter. C M Bidwell & Associates Ltd. now owns 1,555 shares of the company’s stock worth $122,000 after buying an additional 225 shares during the last quarter. Independent Portfolio Consultants Inc. boosted its stake in shares of AptarGroup by 8.6% in the second quarter. Independent Portfolio Consultants Inc. now owns 2,020 shares of the company’s stock worth $160,000 after buying an additional 160 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of AptarGroup by 70.6% in the second quarter. Tower Research Capital LLC TRC now owns 2,192 shares of the company’s stock worth $173,000 after buying an additional 907 shares during the last quarter. Fuller & Thaler Asset Management Inc. acquired a new stake in shares of AptarGroup during the second quarter worth $174,000. Finally, Parametrica Management Ltd acquired a new stake in shares of AptarGroup during the third quarter worth $202,000. Hedge funds and other institutional investors own 88.28% of the company’s stock.

About AptarGroup

AptarGroup, Inc is a provider of a range of packaging, dispensing and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food and beverage markets. The Company has manufacturing facilities located in North America, Europe, Asia and South America.

5 Day Chart for NYSE:ATR

Receive News & Stock Ratings for AptarGroup Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup Inc. and related stocks with our FREE daily email newsletter.